Shedding light to the early diagnose of Alzheimer's disease with a novel imaging biomarker
Researchers from ACHUCARRO collaborate with CIC biomaGUNE in this work in the field of molecular imaging and neuroscience
Abraham Martín and Ana Joya, from the Laboratory of Neuroimaging and biomarkers of inflammation and Estibaliz Capetillo from the Laboratory of Neurobiology of ACHUCARRO are part of an international group of researchers led by Jordi Llop (CIC biomaGUNE, BRTA) that have just published a paper to advance in the diagnosis of Alzheimer's disease.
This work, published in Theranostics, shows the results of a collaboration within an international project, that led to longitudinally evaluate a novel butyrylcholinesterase (BChE) PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer's disease. This discovery opens new windows to translate this finding to humans.